Notably, our IHC staining of human specimens suggest that the proportions of cells with positive staining for the leptin receptor ObR, the macrophage marker CD68, and IL-8 increase as breast cancer progresses from carcinoma in situ to invasive carcinoma. Here, CD68 is linked to in situ carcinoma.